For the year ending 2025-12-31, LIDRW had $33,090K increase in cash & cash equivalents over the period. -$27,886K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -33,958 |
| Depreciation and amortization | 155 |
| Gain on sale of property and equipment, net | 0 |
| Noncash lease expense relating to operating lease right-of-use assets | 211 |
| Gain on termination of operating lease, net | 1,014 |
| Common stock purchase agreement costs | 337 |
| Debt issuance costs | 2,020 |
| Gain on extinguishment of warrant | 64 |
| Inventory write-downs, net of scrapped inventory | 48 |
| Change in fair value of convertible note and warrant liabilities | -1,895 |
| Stock-based compensation | 5,522 |
| Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest | 378 |
| Expected credit losses, net of write-off | 2 |
| Accounts receivable, net | 68 |
| Inventories, current and noncurrent, net | 678 |
| Prepaid and other current assets | 1,054 |
| Other noncurrent assets | -241 |
| Accounts payable | 9 |
| Accrued expenses and other current liabilities | -767 |
| Operating lease liabilities | -236 |
| Other noncurrent liabilities | 0 |
| Net cash used in operating activities | -27,777 |
| Purchases of property and equipment | 109 |
| Proceeds from sale of property and equipment | 0 |
| Proceeds from redemptions and maturities of marketable securities | 23,079 |
| Purchases of marketable securities | 53,768 |
| Net cash provided by (used in) investing activities | -30,798 |
| Proceeds from exercise of stock options | 0 |
| Proceeds from the issuance of convertible notes | 2,950 |
| Payments for convertible note redemptions | 989 |
| Transaction costs related to issuance of convertible note | 658 |
| Taxes paid related to the net share settlement of equity awards | 643 |
| Proceeds from issuance of common stock under the common stock purchase agreements | 90,961 |
| Stock issuance costs related to the common stock purchase agreements | 1,835 |
| Proceeds from exercise of warrant | 1,788 |
| Proceeds from issuance of common stock through the employee stock purchase plan | 91 |
| Net cash provided by financing activities | 91,665 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 33,090 |
| Cash, cash equivalents and restricted cashbeginning of period | 10,266 |
| Cash and cash equivalentsend of period | 43,356 |
AEye, Inc. (LIDRW)
AEye, Inc. (LIDRW)